Stake Purchase • Real Estate

Huiyuan Cowins Technology Invests In Durban Development Co.

On October 6, 2008, Huiyuan Cowins Technology invested in real estate company Durban Development Co. for 335M HKD

Investment Context
  • This is Huiyuan Cowins Technology’s 1st transaction in the Real Estate sector.
  • This is Huiyuan Cowins Technology’s 0th largest (disclosed) transaction.
  • This is Huiyuan Cowins Technology’s 3rd transaction in Taiwan.

Explore All 84 Stake Purchase Real Estate Deals - Search the Database Free


Investment Summary

Date October 6, 2008
Target Durban Development Co.
Sector Real Estate
Investor(s) Huiyuan Cowins Technology
Deal Type Stake Purchase
Deal Value 335M HKD

Target Company

Durban Development Co.

Taipei City, Taiwan
Durban Development Company is principally engaged in building construction, property development and property investment in Taiwan.
Explore More Deals

Browse All 215,156 Deals

FILTER BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Search Free

Investor Overview 1

Investor

Huiyuan Cowins Technology

Hong Kong, China

Category Company
Founded 2003
Sector Manufacturing
Employees321
Revenue 714M HKD (2024)
DESCRIPTION

Huiyuan Cowins Technology is an entity engaged in the processing and manufacture of different kinds of steel sheets and steel pipes which are used by its customers in the manufacture of 3C products, sports equipment, as well as spare parts of household appliances and motor vehicles. Huiyuan Cowins Technology was founded in 2003 and is based in Hong Kong, China.


Deal Context for Investor #
Overall 3 of 3
Sector: Real Estate 1 of 1
Type: Stake Purchase 2 of 2
Country: Taiwan 3 of 3
Year: 2008 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-06-11 Da Cin Property

Hsinchu City, Taiwan

Da Cin Property a site area of approximately 3,664.54 square metres (1,108.52 ping). The site of the Property is zoned as Type B Industrial Area which is mainly for low hazard industrial and ancillary uses.

Buy HK$208M

Explore Related M&A Activity